Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Didanosine/hydroxycarbamide in patients with HIV-1 infections

Trial Profile

Didanosine/hydroxycarbamide in patients with HIV-1 infections

Phase of Trial: Phase II

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Didanosine/hydroxycarbamide (Primary)
  • Indications HIV-1 infections
  • Focus Pharmacodynamics; Therapeutic Use
  • Sponsors Virostatics
  • Most Recent Events

    • 02 Mar 2011 Substudy results presented at the 18th Conference on Retroviruses and Opportunistic Infections.
    • 20 Jul 2010 Status changed from recruiting to completed.
    • 19 Jul 2010 Results presented at the the 18th International AIDS Conference (IAC-2010) in July 2010, according to a ViroStatics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top